Melioidosis is a severe infection caused by the flagellated bacterium Burkholderia pseudomallei. The nonsense polymorphism TLR5 1174C4T is associated with improved outcome in Thais with melioidosis. We hypothesized that other TLR5 variants may modulate the host response and determine outcome in melioidosis. We genotyped 12 TLR5 variants selected de novo from the HapMap database and examined the association of each with cytokines induced by flagellin stimulation of whole blood from healthy Thai subjects. We found a blunted cytokine response for three related markers that were in linkage disequilibrium (LD) with a non-synonymous variant, TLR5 1846T4C . Carriers of TLR5 1846T4C had broadly impaired cytokine responses induced by flagellin. TLR5 1846T4C was associated with protection against death in melioidosis patients (odds ratio: 0.62, 95% confidence interval: 0.42-0.93, P ¼ 0.021). We observed no impairment in TLR5 1846C -dependent nuclear factor kB activation, however, suggesting an alternative mechanism for the effect. We found that TLR5 1846T4C was in strong LD with TLR5 1174C4T . Many of the blunted cytokine responses observed and the association of TLR5 1846T4C with survival in melioidosis patients may be attributable to TLR5 1174C4T , but we could not exclude an independent effect of TLR5 1846T4C. These data identify novel associations for TLR5 1846T4C , enhance our understanding of TLR5 genetic architecture in Thais and highlight the role of TLR5 in melioidosis.
INTRODUCTION
A primary host defence mechanism against invading pathogens is the innate immune response, which is initiated upon the recognition of pathogen-associated molecular patterns by pathogen sensors such as toll-like receptors (TLRs). 1 These transmembrane-receptors use leucine-rich repeat extracellular domains to distinguish the highly conserved structure of pathogens from self-components and mediate the signal via a cytoplasmic receptor homology domain. 2 At least 10 types of TLRs are present with different density on various cell types in blood and tissue, such as macrophage, monocyte, dendritic cells, neutrophils and epithelial cells. 1, 3 Each TLR recognizes a different group of pathogen-associated molecular patterns including lipolysaccharide and flagellin from Gramnegative bacteria, lipoteichoic acid from Gram-positive bacteria, bacterial DNA, viral RNA and envelope glycoproteins. The activation of TLRs leads to a massive production of a variety of immune mediators, which are important triggers for inflammatory responses and the connection to adaptive immune response to infections. [4] [5] [6] TLR5 recognizes flagellin and signals in a MyD88-dependent manner to activate nuclear factor kB (NF-kB). 7, 8 This is in contrast to TLR2 or TLR4, which use the additional adaptor molecule toll-interleukin1 receptor (TIR) domain containing adaptor protein (TIRAP) to recruit MyD88. TLR4 may also signal in a MyD88-independent but TIR-domain-containing adaptor-inducing interferon-b (TRIF)/TRIF-related adaptor molecule (TRAM) -dependent manner. The final result of these different pathogenassociated molecular patterns and TLR engagement is the activation of downstream signalling pathways, ultimately resulting in the production of several immune mediators.
TLR5 is the only TLR that responds to flagellin (FliC), a main protein of flagella. Human TLR5 is a type I transmembrane protein with a 642-amino-acid leucine-rich extracellular domain, an 18-residue transmembrane domain, and a 198-residue cytoplasmic Toll homology signalling domain. 9 Several Gram-negative bacteria use flagella to direct movement and facilitate pathogenicity in hosts. [10] [11] [12] The flagellins from flagellated bacteria share a common structure, which binds to TLR5 and precipitates a MyD88-and NF-kB-dependent host response. 3 Melioidosis is a tropical disease caused by Burkholderia pseudomallei, a flagellated Gram-negative soil saprophyte. The disease is endemic in parts of Southeast Asia and Northern Australia. 13 In northeast Thailand, the overall melioidosis mortality rate is 40%, and reaches 90% in severe infection. 14, 15 The importance of the innate immune response in control of infection and pathophysiology of lethal melioidosis is documented in several studies. In septicaemic melioidosis, TLRs-including TLR5-and associated molecules are highly expressed. 16 Melioidosis patients who die have elevated plasma levels of pro-inflammatory cytokines interleukin (IL)-12, -18, -15 and interferon-g compared with those who survive. 17 We have previously demonstrated that a common nonsense TLR5 polymorphism that truncates the receptor and abolishes flagellin signalling (TLR5 1174C4T ) 9 is associated with improved outcome from melioidosis. 18 These data demonstrate the importance of flagellin sensing in melioidosis. Others have shown strong evidence for selection of TLR5 polymorphisms. 19 We hypothesized that other TLR5 genetic variants may modulate flagellin signalling and determine outcome from melioidosis independently of TLR5 1174C4T . To test this hypothesis, we analysed the association of candidate TLR5 polymorphisms identified de novo from Asian HapMap databases with whole blood responses to flagellin in healthy Thai subjects; examined the association of a tagged coding variant with death from melioidosis; and assayed innate immune activation by the coding variant in transfected cells.
RESULTS

Blood cytokine responses to flagellin are highly correlated
We stimulated blood from 300 healthy Thai subjects with Salmonella typhimurium flagellin and measured eight cytokine and chemokine levels 6 h later using a multiplex bead assay (Chantratita et al., submitted for publication). 18 The median age of subjects was 33 years, interquartile range: 24-41. One hundred and twenty-seven (42.3%) of the three hundred subjects were female. Given nonnormal distributions of the cytokine data, we performed log transformations before analyses, resulting in normally distributed residuals. We next examined the data to determine whether any of the eight mediators were highly correlated. We found that IL-6 was highly correlated (pairwise correlation coefficient (r)40.73) with all mediators (IL-8, TNF-a, IL-10, monocyte chemoattractant protein-1 (MCP-1), granulocyte colony-stimulating factor (G-CSF) and IL-1b) except IL-1ra (Table 1) . As a result, we restricted our subsequent analyses to IL-6 and IL-1ra.
TLR5 variants are associated with flagellin-induced cytokine responses in blood We then tested whether genetic variants in TLR5 were associated with IL-6 or IL-1ra induced by flagellin stimulation of blood. We identified 12 candidate single-nucleotide polymorphisms (SNPs) in TLR5 selected as described in the methods (rs2072493, rs5744173, rs2096142, rs5744175, rs2241096, rs5744176, rs2241097, rs2353476, rs5744113, rs5744166, rs17163737, rs5744167). We genotyped these variants in the 300 subjects. No assays failed but there was no variation in five variants so these were not considered further. The call rates for the seven remaining variants (rs2072493, rs2096142, rs2241096, rs2241097, rs2353476, rs5744113, rs17163737) were 100% and no variant failed a test for Hardy-Weinberg equilibrium. We found that three variants, rs2096142, rs2353476 and rs5744113, were significantly associated with both IL-6 and IL-1ra in additive models ( Table 2 ). We did not adjust for multiple comparisons given the possibility that these variants were not independent. On further investigation, rs2096142, rs2353476 and rs5744113 were in very high linkage disequilibrium (LD) with each other (r 2 ¼ 0.98-1.0; Figure 1 ). We then searched the HapMap Han Chinese in Beijing population using the Genome Variation Server (http://gvs.gs.washington.edu/ GVS134/) to identify whether the haplotype containing these Abbreviations: IL, interleukin; TNF, tumour necrosis factor. a Pairwise correlation coefficient (r) between log-transformed cytokines induced by stimulation of whole blood from 300 healthy subjects with 500 ng ml À 1 flagellin. variants also contained a non-synonymous coding variant that might be functional. We found that the LD among the three variants was also very high in this population (r 2 ¼ 0.93-1.0). The only coding variant we identified in LD with the three variants was rs5744174 (r 2 ¼ 0.63-0.68). This non-synonymous coding variant exchanges T for C at position 1846, corresponding to an aminoacid change from phenylalanine to leucine at position 616 in the extracellular domain. Recently published evidence suggests that this variant has been subjected to significant selective pressure in Yorubans. 19 The genomic evolutionary rate profiling score, indicating variability across mammals, is À 11.2. 20 TLR5 1846T4C is associated with flagellin-induced cytokine responses in blood We then genotyped TLR5 1846T4C in the 300 Thai subjects (call rate 100%) and found that the LD with our initial three variants was modest (r 2 B0.5; Figure 1 ). The minor allele frequency of TLR5 1846T4C was 0.22 and the variant was in Hardy-Weinberg equilibrium (P ¼ 0.76). We tested whether TLR5 1846T4C was associated with cytokine responses to flagellin using an additive genetic model. We found that the variant was highly associated with lower levels of all mediators except MCP-1 ( Table 3 and Figure 2 ). Monocyte counts, age and sex are associated with cytokine responses to various bacterial ligands (Chantratita et al., unpublished observations). Inclusion of these variables in the model had only modest effects on the point estimates ( Supplementary Table 1 ).
TLR5 1846T4C is associated with survival from melioidosis
To determine whether TLR5 1846T4C was associated with clinical outcome from flagellated infection, we genotyped the variant in a cohort of Thai subjects with melioidosis. Melioidosis is a infection caused by the Gram-negative and flagellated soil saprophyte B. pseudomallei. Mortality is very high in northeast Thailand. This cohort has been previously described. 18, 21 Of 600 individuals with melioidosis, the median age was 49 years, interquartile range: 39-60 and 274 (45.7%) were female. One hundred and forty-three (23.8%) died during their hospitalization or were discharged home in extremis for palliative care. DNA was available for genotyping in 588 subjects for whom outcome at hospital discharge was known.
The variant was genotyped in 580 individuals (call rate 98.6%) and did not deviate from Hardy-Weinberg equilibrium in survivors to hospital discharge (P ¼ 0.89). We found that TLR5 1846T4C was significantly associated with protection against in-hospital death in an unadjusted analysis (Table 4 ). We then tested whether the variant was associated with any pre-existing condition (diabetes, chronic liver disease, renal insufficiency and steroid use) to identify potential confounders to consider in the analysis but found no associations. In the adjusted model, we included factors that were independently associated with death: age, diabetes, renal insufficiency, pneumonia, bacteraemia and urinary tract infection. This adjusted model confirmed a significantly protective effect of TLR5 1846T4C against death from melioidosis (odds ratio: 0.62, 95% confidence interval: 0.42-0.93, P ¼ 0.021). Kaplan-Meier curves demonstrating in-hospital survival for carriers of each genotype were significantly different (P ¼ 0.029; Figure 3 ).
TLR5 1174C4T underlies some of the effect of TLR5 1846T4C on death in melioidosis We have previously shown an association of TLR5 1174C4T that is protective against death in melioidosis. 18 TLR5 1174C4T is not listed in the HapMap database but we hypothesized that TLR5 1174C4T might be in LD with TLR5 1846T4C and potentially explain the association of TLR5 1846T4C with outcome from melioidosis. We first tested whether TLR5 1846T4C and TLR5 1174C4T were in LD in the 300 healthy subjects. We found that r 2 ¼ 0.19 ( Figure 1 ) but D 0 ¼ 1.0 and the association between genotypes displayed in a contingency table was significant (P ¼ 4 Â 10 À 15 ), indicating that the two variants were in LD. No subjects with the major genotype TLR5 1846TT carried a TLR5 1174T allele but 25% of the TLR5 1846TC subjects and 44% of the TLR5 1846CC subjects did ( Table 5 ). We next tested the association of TLR5 1846T4C with death in melioidosis in the 500 hospitalized subjects who did not carry the rare variant of TLR5 1174C4T and found that the effect was no longer significant (adjusted odds ratio: 0.87, 95% confidence interval: 0.56-1.33, P ¼ 0.51). However, the power to reject the null hypothesis of no association between death and TLR5 1846T4C in this subset that is independent of TLR5 1174C4T is p50% when the true odds ratio is X0.62. A haplotype analysis of both variants on death confirmed a non-significant effect of TLR5 1846C on death in the absence of TLR5 1174T and showed a significant protective association of both TLR5 1174T and TLR5 1846C with death ( Table 6 ). The frequency of the haplotype containing TLR5 1174T but not TLR5 1846C was too low to The association of TLR5 1846T4C on flagellin-induced cytokine release is partly attributable to TLR5 1174C4T We have previously shown that TLR5 1174C4T significantly reduces all eight cytokine responses induced by stimulation of blood by flagellin. 18 This work extended original studies by Hawn et al. who also demonstrated the lack of flagellin-induced NF-kB activation by this variant, independent of TLR5 1846T4C . 9 To investigate whether TLR5 1846T4C was associated with reduced cytokine release in whole blood independent of TLR5 1174C4T , we repeated our analysis of the effect of TLR5 1846T4C on cytokine release in response to flagellin excluding carriers of the TLR5 1174C4T variant allele. In comparison to all subjects, we found that the effect of TLR5 1846T4C on lowered cytokine response in this subset was attenuated for all cytokines (excluding MCP-1). The relative reduction in the effect of TLR5 1846T4C ranged from 43% for IL-6 to 16% for IL-1ra. The point estimates were uniformly negative and the P value for a joint test of all eight differences, accounting for correlation among the cytokines, was 0.08. The associations between TLR5 1846T4C and reduced cytokine response remained significant individually only for G-CSF and IL-1b (Table 7 ). These data suggest that the association of TLR5 1846T4C with impaired cytokine release may be partly attributable to TLR5 1174C4T .
TLR5 1846T4C is not dysfunctional in NF-kB signalling To further investigate whether TLR5 1846T4C was independently associated with altered flagellin signalling, we performed site-directed mutagenesis on a previously described TLR5 construct 9 to construct a mutant TLR5 plasmid corresponding to TLR5 1846T4C . Sequence verification confirmed the base change at position 1846 and the absence of any other known non-synonymous variation in the full TLR5-coding sequence in the plasmid (Figure 4a ). We transfected HEK 293 cells with TLR5 1846T or TLR5 1846C and assayed NF-kB activation by luciferase reporter assay following stimulation with 50, 100 or 200 ng ml À 1 flagellin. The cells transfected with TLR5 1846C showed no difference in NF-kB activation compared with TLR5 1846T -transfected cells (Figure 4b ).
These data indicated that in this construct TLR5 1846T4C does not impair flagellin-driven innate immune activation via NF-kB.
Differential LD of variants with TLR5 1846T4C across populations In light of the evidence in favour of selection for TLR5 1846T4C in Yorubans, 19 but our inability to conclusively determine a clinical effect of TLR5 1846T4C independent of TLR5 1174C4T in Thais, we hypothesized that there may be significant population-level differences in LD structure in TLR5. We examined the distribution of variants in LD with TLR5 1846T4C in three populations (Yorubans, Utah residents with ancestry from northern and western Europe, and Han Chinese) sequenced by the 1000 Genomes Project. 22 The degree of LD between TLR5 1846T4C and TLR5 1174C4T was comparable in the three populations (r 2 ¼ 0.26, 0.12, 0.16; D 0 ¼ 1.0, 1.0, 1.0, respectively) raising the possibility that positive selection for TLR5 1846T4C in Yorubans may be related to TLR5 1174C4T . However, there were marked inter-population differences in the degree of LD between other variants and TLR5 1846T4C ( Figure 5 ). Overall, the Yoruban population differed the most from the other two populations. Moreover, the LD structure of the entire TLR5 gene differed greatly across the three populations ( Supplementary Figures 1 and 2) . Thus, additional variation in TLR5 may confound differential evolutionary and clinical associations. Abbreviations: CI, confidence interval; OR, odds ratio. a 0 indicates major allele and 1 indicates minor allele at each of the two TLR5 loci. The major haplotype (00) is set as the reference; the 10 haplotype is not analysed due to its low frequency. Associations are determined by logistic regression, adjusting for age, diabetes, renal insufficiency, pneumonia, bacteraemia and urinary tract infection. 
DISCUSSION
The results of our study identify a tagged TLR5 non-synonymouscoding variant, TLR5 1846T4C , that is associated with reduced cytokine responses to flagellin in human blood and further show that it is associated with protection against death in melioidosis. In vitro studies demonstrate that the variant does not alter NF-kB activation induced by flagellin, however, and the cytokine and clinical effects observed are in large part driven by TLR5 1174C4T , a previously described hypofunctional variant that is in LD with TLR5 1846T4C . Collectively, these data identify new biological and clinical associations for TLR5 1846T4C , advance our understanding of genetic variation in TLR5 in Thais, and confirm the relevance of TLR5 variation in determining outcome in melioidosis.
Although it is known that TLRs are important in regulating innate immune responses, 3 only a few reports have demonstrated the clinical significance of TLR5 polymorphisms in bacterial infections. Studies demonstrating an association have mostly been restricted to a functional nonsense polymorphism TLR5 1174C4T . 9, 18 Accordingly, we searched for additional genetic variation in TLR5 that might have functional effects and clinical relevance in melioidosis. Knowledge of innate immune genetic variation in Thais is limited, necessitating that we choose candidate variants based on publically available data from other populations. Our data therefore provide the first published data on frequency and LD patterns of TLR5 genetic variation in Thais.
Our main finding in this work is that TLR5 1846T4C (F616L) is associated with broadly reduced cytokine responses to flagellin and protection against death in melioidosis. Other investigators have reported associations of TLR5 1846T4C with immune responses and clinical disease. The variant is associated with earlier spontaneous Hepatitis B virus e antigen (HBeAg) seroconversion (disappearance of serum HBeAg and the presence of anti-HBeAg for 46 months) and higher levels of interferon-g production in Taiwanese patients with chronic Hepatitis B infection. 23 TLR5 1846T4C is also associated with gastric cancer and interacts with Helicobacter pylori infection in a cohort of Chinese subjects. 24 The variant is also associated with higher measles-specific interferon-g responses. 25 The associations with viral infections raise the question of a role for this variant that is unrelated to flagellin sensing.
A key question that arises from our data is whether TLR5 1846T4C has a biological or clinical effect that is independent of the nonsense polymorphism with which it is in LD, TLR5 1174C4T. Notably, we did not observe any impairment in NF-kB activation upon stimulation of cells expressing TLR5 1846C alone. This observation confirms the results of other investigators. 9, 26 In contrast, a more recent study reports a TLR5 1846C -dependent decrement in NF-kB activation. 19 Although in the extracellular domain, amino-acid 616 is outside the known flagellin-binding sites 27, 28 and variation at this site is predicted to be benign by Polyphen2. 29 A potential explanation for observed differences between investigators is the source of the TLR5 plasmids studied in these experiments. We show marked differences in LD structure in TLR5 across populations and potentially confounding effects of additional TLR5 variation in plasmids from subjects of different ancestries. In addition, a plasmid generated by mutagenesis of a single locus may yield different functional effects than DNA derived from a carrier of the desired genotype (and accompanying haplotype). We largely attribute our associations of TLR5 1846T4C with blunted whole blood cytokine responses and improved clinical outcome to TLR5 1174C4T . However, some of the effects of TLR5 1846T4C on G-CSF and IL-1b release in whole blood persisted despite excluding carriers of TLR5 1174C4T from our analysis. Our study of the association of TLR5 1846T4C with death from melioidosis in the absence of TLR5 1174C4T was underpowered and therefore inconclusive. Moreover, in contrast to their observations for TLR5 1846T4C , Wu et al. did not find that TLR5 1174C4T was associated with age of HBeAg seroconversion. 23 Thus, we cannot exclude the possibility that TLR5 1846T4C has an immunomodulatory effect independent of TLR5 1174C4T . Further work to elucidate the functional effects of TLR5 variants in different populations is needed.
Our study has several limitations. We cannot exclude that there may be additional interactive effects of unmeasured TLR5 variation that could alter our results. We analysed a relatively restricted number of TLR5 variants in our subjects but we anticipate analysing this region more intensively in the future. Although population stratification may confound any genetic analysis, we have previously shown that we did not detect significant evidence of this in our Sappasithiprasong Hospital cohort. 18 In conclusion, we demonstrate novel biological and clinical associations for TLR5 1846T4C , present new information about TLR5 genetic structure in Thais, and underscore the importance of understanding the role of TLR5 in modulating outcome in melioidosis. Further work is needed to dissect the relative biological contributions of differential TLR5 variation in diverse populations.
MATERIALS AND METHODS
Human subjects
Immuno-assay studies. Three-hundred healthy Thai subjects donating blood at the blood donation centre at Sappasithiprasong Hospital (Ubon Ratchathani, Thailand) in 2010 were recruited for participation as previously described. 18 Subjects were included if their stated age was between 18 and 60 years, and did not report any history of immunodeficiency or inflammatory conditions, chronic diseases, pregnancy in the past 6 months, anti-inflammatory medication use in the past week, antibiotic use in the past month, vaccination in the past 6 months, heavy exercise or alcohol consumption in the past 24 h or smoking in the past month. Those who met enrolment criteria gave written informed consent to participate and provided a post-donation blood sample.
Melioidosis cohort. The study cohort has been previously described. 18 Clinical data and blood were obtained from 588 patients with melioidosis admitted to Sappasithiprasong Hospital, from 1999 to 2005. A study team screening patients with clinical signs of infection cultured blood, urine and other relevant samples (for example, abscess aspirates) for B. pseudomallei. Inclusion into the melioidosis cohort required a positive culture for B. pseudomallei from a sample collected by the study team or independently by hospital clinicians. For the analyses of genotype with death from melioidosis, deaths were defined as those individuals who died during their hospitalization or were discharged home in extremis for palliative care. Consent for enrolment into clinical studies of melioidosis was obtained from subjects or their representatives at the time of recruitment.
The 
Immuno-assays
Three hundred and eighty microlitres of fresh whole blood in citrate mixed 1:1 with RPMI media was added to pre-prepared plates containing 20 ml of various stimulants. For this study, the stimulants analysed were S. typhimurium flagellin at a final concentration of 500 ng ml À 1 and Escherichia coli lipolysaccharide 10 ng ml À 1 (List Biological Laboratories, Campbell, CA, USA). Plates were incubated at 37 1C on a shaking incubator under 5% CO 2 for 6 h before being spun down and plasma removed and frozen at À 80 1C. IL-6, IL-8, TNF-a, IL-10, MCP-1, IL-1ra, G-CSF and IL-1b were later assayed in duplicate on a multiplex bead system (Luminex, Austin, TX, USA) using reagents from R&D Systems (Minneapolis, MN, USA). If either (or both) duplicate(s) was less than the lower limit of detection of the assay, it was assigned the lowest detectable value of any of the 300 subjects' duplicate raw results for that cytokine induced by the same stimulant, a form of data imputation. The amended duplicate values were then averaged to provide a final cytokine concentration. A complete blood count with differential was performed in the hospital clinical laboratory for each subject at the time of phlebotomy.
Genotyping DNA was extracted from whole blood of healthy donors using the QIAamp DNA Blood Midi Kit (Qiagen, Hilden, Germany) and from whole blood of patients with melioidosis using Nucleon BACC3 kits (GE Healthcare, Little Chalfont, UK). SNP selection of non-synonymous-coding variants was performed by searching the HapMap project database (http://hapmap.ncbi.nlm.nih.gov) and based on functional prediction using a FastSNP analysis (http://fastsnp.ibms.sinica.edu.tw). 30 Tag SNPs were selected from the Han Chinese in Beijing and Japanese in Tokyo populations in the HapMap database for variants with a minor allele frequency at least 2% using the HapMap tag-SNP picker option. TLR5 1174C4T (rs5744168) was not listed in the HapMap database for these populations. Genotyping was performed using Fluidigm SNPtype assays on a Biomark microfluidics realtime PCR system or using ABI TaqMan assays on an ABI Prism 7900 (Applied Biosystems, Carlsbad, CA, USA).
Cloning and site-directed mutagenesis
A T to C mutation in TLR5 at position 1846 was constructed with a QuikChange II site-directed mutagenesis kit (Stratagene, Santa Clara, CA, USA). The coding region of TLR5 was amplified from 7.5 ng plasmid template TLR5-RNF-V5-pEF6, which contained full-length human TLR5coding region cloned into the pEF6/V5-His TOPO expression vector (Invitrogen, Carlsbad, CA, USA) 9 in a 25 ml reaction volume. TLR5-RNF-V5-pEF6 was a gift from Thomas R Hawn, University of Washington, Seattle, WA, USA. Mutagenic primers were designed from TLR5 mRNA sequence (Gen Bank accession no. AB060695.1) using software from http://labtools.stratagene.com/QC. The forward primer was modified to replace T with C at the position 1846 corresponding to rs5744174. The sequences of primers from 5 0 to 3 0 were as follows: F-5 0 -GTGTACCCTGACTCGCTCTCTGGGGTTTCCC-3 0 and R-5 0 -GGGAAACCCCA GAGAGCGAGTCAGGGTACAC-3 0 . The PCR reaction mixture was performed TLR5 variation and melioidosis N Chantratita et al with PfuUltra high-fedelity DNA polymerase according to the protocol described by manufacturer and the conditions were as follows: initial denaturation at 95 1C for 1 min; 12 cycles of denaturation at 95 1C for 1 min, annealing at 60 1C for 1 min and extension at 68 1C for 15 min; and the reaction was cooled to 4 1C for 1 min. The parental methylated and hemimethylated DNA remaining in amplification product was digested with 1 ml of 10 U ml À 1 Dpn I restriction enzyme at 37 1C for 1 h. The mutant TLR5 plasmid (containing 5840 bp plasmid and 2574 bp TLR5 insert) was transformed into E. coli DH5a. The clones with mutant constructs were selected from plates containing 100 mg ml À 1 ampicillin. Colonies containing the desired plasmids were analysed by PCR using T7 promoter forward and BGH reverse primers flanking the TLR5 mutant alleles from 5 0 to 3 0 as follows: F-5 0 -TAATACGACTCACTATAGGG-3 0 and R-5 0 -TAGAAGGCACAGTCGAGG-3 0 . The plasmids were extracted from E. coli using a QIAprep spin miniprep kit (Qiagen) and DNA sequence was verified by DNA sequencing (Macrogen, Seoul, Korea). The sequence of the mutant clone was analysed and aligned with the sequence of TLR5-RNF-V5-pEF6 wild type using Seqman software (Laser gene) version 8 (DNASTAR Inc., Madison, WI, USA) and MEGA version 5. 31 The plasmid from the selected clone was extracted for HEK 293 cell transfection experiment using Endofree plasmid purification (Qiagen).
Transfections
HEK 293 cells (CRL-1573, ATCC) were transfected and stimulated as described previously with some modifications. 9, 18 HEK 293 cells were cultured in complete Dulbecco's modification of Eagle's medium without sodium pyruvate and were supplemented with L-glutamine, 4.5 g l À 1 glucose (Mediatech Cellgro, Manassas, VA, USA) and 10% fetal bovine serum (Hyclone, South Logan, UT, USA). Transfection was performed with 5 Â 10 4 cells per well HEK 293 cells in a 96-well plate with 100 ml transfection reagent containing 0.5 ml Polyfect reagent (Qiagen), 10 ng pNiFty-Luc firefly luciferase reporter (Invivogen, San Diego, CA, USA), 1 ng pRL-TK Renilla luciferase control reporter (Promega, Madison, WI, USA) and 40 ng of plasmid (TLR5 1846T wild type or TLR5 1846C variant or pEF6 control). Before transfection, the plasmids were prepared in Dulbecco's modification of Eagle's medium without fetal bovine serum and mixed with Polyfect reagent by vortexing for 10 s, incubated at room temperature for 10 min and the volume adjusted to 100 ml with complete Dulbecco's modification of Eagle's medium.
Transfected HEK 293 cells were stimulated with 100 ml of 100, 200 and 400 ng ml À 1 of ultra purified flagellin from S. typhimurium (Invivogen) to obtain final concentration 50, 100 and 200 ng ml À 1 . The plate was centrifuged at 200 Â g at room temperature for 3 min and incubated at 37 1C with 5% CO 2 for 24 h. The cells were washed two times with 100 ml Dulbecco's phosphate-buffered saline without Ca2 þ or Mg2 þ (Mediatech Cellgro), lysed with 40 ml passive lysis buffer with shaking at room temperature for 15 min. Twenty microlitres of lysate was measured for luminescence using the Dual-Lucifearase Reporter Assay (Promega) on a GloMax Multi Detection System (Promega). The experiment was performed in triplicate.
Statistics
As immune-assay cytokine concentrations were often non-normally distributed, they were log 10 transformed to obtain normally distributed residuals for estimation of pairwise correlations and for estimation of genotype association with cytokine levels. Associations between genotype as a predictor of cytokine concentration were performed using linear regression, coding the genotype to reflect dominant, recessive or additive genetic models. This is equivalent to testing for differences in mean cytokine levels between genotype groups (and allows adjustment for confounding). Where indicated, this model was adjusted for age, sex and monocyte count. Associations between genotype or haplotype and death were tested using logistic regression, assuming an additive genetic model. This model was adjusted for age, diabetes, renal insufficiency, pneumonia, bacteraemia and urinary tract infection. Survival analyses were performed with a test for trend across genotypes. Statistics were performed with R (version 2.15.2; GNU project (http://www.r-project.org)) or with Stata 11.2 (StataCorp LP, College Station, TX, USA), incorporating the functions pwld for test for LD, genhw to test for deviation from Hardy-Weinberg equilibrium using the exact test, and haplologit for haplotype analyses. Golden Helix SNP and Variation Suite software (Golden Helix, Bozeman, MT, USA) was used to calculate LD and generate maps. A two-sided P value p0.05 was considered significant.
